Chemed (NYSE:CHE) Issues FY 2025 Earnings Guidance

Chemed (NYSE:CHE) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 24.950-25.450 for the period, compared to the consensus estimate of 24.890. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of analyst reports. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada decreased their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

Chemed Stock Up 4.1 %

Shares of NYSE CHE traded up $22.45 during trading hours on Thursday, hitting $568.24. 8,359 shares of the stock were exchanged, compared to its average volume of 89,309. The company has a market cap of $8.55 billion, a PE ratio of 29.38, a PEG ratio of 2.15 and a beta of 0.48. Chemed has a 12 month low of $512.12 and a 12 month high of $654.62. The firm has a fifty day moving average price of $543.86 and a 200-day moving average price of $563.11.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s payout ratio is currently 10.11%.

Insider Activity

In other Chemed news, VP Brian C. Judkins bought 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.